Fractyl Health, Inc. financial data

Symbol
GUTS on Nasdaq
Location
3 Van De Graaff Drive, Suite 200, Burlington, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 306 %
Quick Ratio 0.45 %
Debt-to-equity 468 %
Return On Equity -596 % -1383%
Return On Assets -105 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.3M shares +4.93%
Common Stock, Shares, Outstanding 49.9M shares +4.18%
Entity Public Float 144M USD
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 49M shares +2.39%
Weighted Average Number of Shares Outstanding, Diluted 49M shares +2.39%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 50K USD -35.1%
Research and Development Expense 79.9M USD +57.4%
Operating Income (Loss) -99.8M USD -39.9%
Nonoperating Income (Expense) 75K USD -99.5%
Net Income (Loss) Attributable to Parent -99.8M USD -79.8%
Earnings Per Share, Basic -2 USD/shares +89.9%
Earnings Per Share, Diluted -2 USD/shares +89.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.3M USD -78.2%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 73K USD 0%
Assets, Current 26.7M USD -75%
Property, Plant and Equipment, Net 2.97M USD -6.53%
Operating Lease, Right-of-Use Asset 27.6M USD -5.18%
Other Assets, Noncurrent 458K USD -86.1%
Assets 62M USD -57.7%
Accounts Payable, Current 3.91M USD +71%
Liabilities, Current 21.8M USD +52.9%
Operating Lease, Liability, Noncurrent 26.7M USD -4.54%
Other Liabilities, Noncurrent 838K USD -13.1%
Liabilities 80.2M USD +5.99%
Retained Earnings (Accumulated Deficit) -467M USD -27.2%
Stockholders' Equity Attributable to Parent -18.2M USD -126%
Liabilities and Equity 62M USD -57.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.1M USD -114%
Net Cash Provided by (Used in) Financing Activities 171K USD -99.8%
Net Cash Provided by (Used in) Investing Activities -448K USD +57.7%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 49.9M shares +4.18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -25.4M USD -129%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 26.5M USD -75.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.09M USD +76.2%
Deferred Tax Assets, Valuation Allowance 120M USD +24.5%
Deferred Tax Assets, Gross 127M USD +22%
Operating Lease, Liability 32.3M USD
Depreciation 290K USD +447%
Payments to Acquire Property, Plant, and Equipment 448K USD -57.7%
Lessee, Operating Lease, Liability, to be Paid 55.2M USD -9.35%
Property, Plant and Equipment, Gross 4.57M USD -14%
Operating Lease, Liability, Current 5.03M USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.82M USD -2.69%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.98M USD +2.73%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 24.4M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.74M USD -0.78%
Deferred Tax Assets, Operating Loss Carryforwards 68.9M USD +10.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.91M USD +3%
Additional Paid in Capital 449M USD +2.47%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 8.61M USD -24.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%